Related references
Note: Only part of the references are listed.Novel Interaction of Ornithine Decarboxylase with Sepiapterin Reductase Regulates Neuroblastoma Cell Proliferation
Ingo Lange et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
A Phase II Trial of a Multi-Agent Oral Antiangiogenic (Metronomic) Regimen in Children With Recurrent or Progressive Cancer
Nathan J. Robison et al.
PEDIATRIC BLOOD & CANCER (2014)
Polyamine blockade promotes antitumor immunity
Candace S. Hayes et al.
ONCOIMMUNOLOGY (2014)
Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Medecins Sans Frontieres Experience in the Democratic Republic of the Congo
Emilie Alirol et al.
CLINICAL INFECTIOUS DISEASES (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
Julie R. Park et al.
PEDIATRIC BLOOD & CANCER (2013)
Unbiased Metabolite Profiling Indicates That a Diminished Thymidine Pool Is the Underlying Mechanism of Colon Cancer Chemoprevention by Alpha-Difluoromethylornithine
Mavee Witherspoon et al.
CANCER DISCOVERY (2013)
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma
Laura D. Gamble et al.
FRONTIERS IN ONCOLOGY (2012)
The mechanisms by which polyamines accelerate tumor spread
Kuniyasu Soda
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Polyamine transport is mediated by both endocytic and solute carrier transport mechanisms in the gastrointestinal tract
Takeshi Uemura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of alpha-Difluoromethylornithine in Subjects with Previous History of Skin Cancer
Howard H. Bailey et al.
CANCER PREVENTION RESEARCH (2010)
Neuroblastoma: Therapeutic strategies for a clinical enigma
Shakeel Modak et al.
CANCER TREATMENT REVIEWS (2010)
Levels of Rectal Mucosal Polyamines and Prostaglandin E2 Predict Ability of DFMO and Sulindac to Prevent Colorectal Adenoma
Patricia A. Thompson et al.
GASTROENTEROLOGY (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
Robert J. Rounbehler et al.
CANCER RESEARCH (2009)
Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma
Nicholas F. Evageliou et al.
CLINICAL CANCER RESEARCH (2009)
Associations of a Polymorphism in the Ornithine Decarboxylase Gene with Colorectal Cancer Survival
Jason A. Zell et al.
CLINICAL CANCER RESEARCH (2009)
Genetic polymorphism in ornithine decarboxylase and risk of breast cancer
Iain Brown et al.
FAMILIAL CANCER (2009)
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto et al.
LANCET (2009)
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
Frank L. Meyskens et al.
CANCER PREVENTION RESEARCH (2008)
Ornithine Decarboxylase Inhibition by α-Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in Neuroblastoma
Dana-Lynn T. Koomoa et al.
CANCER RESEARCH (2008)
ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
Michael D. Hogarty et al.
CANCER RESEARCH (2008)
Medical treatment of hirsutism
Ulrike Blume-Peytavi et al.
DERMATOLOGIC THERAPY (2008)
Identification and characterization of a diamine exporter in colon epithelial cells
Takeshi Uemura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
Robert A. Casero et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Polyamines and neoplastic growth
A. E. Pegg et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Inflammation and polyamine catabolism: the good, the bad and the ugly
N. Babbar et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells
CJ Wallick et al.
ONCOGENE (2005)
N1,N12-diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers
K Hiramatsu et al.
CLINICAL CANCER RESEARCH (2005)
Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk
K Visvanathan et al.
JOURNAL OF UROLOGY (2004)
Polyamines and cancer: Old molecules, new understanding
EW Gerner et al.
NATURE REVIEWS CANCER (2004)
The MYCN oncoprotein as a drug development target
XH Lu et al.
CANCER LETTERS (2003)
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene
ME Martínez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc
M Auvinen et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Share Paper
